Herbert Virgin's Insider Trades & SAST Disclosures
Herbert Virgin's most recent trade in Vir Biotechnology Inc was a trade of 70,177 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on Aug. 9, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Herbert Virgin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 09 Aug 2022 | 70,177 | 254,584 (0%) | 0% | 1.5 | 107,371 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 70,177 | 140,328 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 7,916 | 125,416 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.40 per share. | 09 Aug 2022 | 7,916 | 262,500 (0%) | 0% | 10.4 | 82,287 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 10 Mar 2022 | 9,000 | 184,407 (0%) | 0% | 1.5 | 13,770 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 9,000 | 210,505 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 70,000 | 175,407 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 1,375 | 219,505 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 22 Feb 2022 | 1,375 | 176,782 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Feb 2022 | 1,375 | 175,407 (0%) | 0% | 30 | 41,250 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 17 Feb 2022 | 2,293 | 105,407 (0%) | 0% | 31.9 | 73,218 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 33.94 per share. | 08 Feb 2022 | 1,375 | 107,700 (0%) | 0% | 33.9 | 46,668 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 1,375 | 220,880 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 08 Feb 2022 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 25 Jan 2022 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2022 | 1,375 | 222,255 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 32.46 per share. | 25 Jan 2022 | 1,375 | 107,700 (0%) | 0% | 32.5 | 44,633 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 35.10 per share. | 11 Jan 2022 | 1,375 | 107,700 (0%) | 0% | 35.1 | 48,263 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2022 | 1,375 | 223,630 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 11 Jan 2022 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 39.95 per share. | 28 Dec 2021 | 1,375 | 107,700 (0%) | 0% | 39.9 | 54,931 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 1,375 | 225,005 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 28 Dec 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 14 Dec 2021 | 2,750 | 110,450 (0%) | 0% | 1.5 | 4,208 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,750 | 226,380 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 14 Dec 2021 | 2,750 | 107,700 (0%) | 0% | 50 | 137,500 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 1,375 | 229,130 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 45.88 per share. | 14 Dec 2021 | 1,375 | 107,700 (0%) | 0% | 45.9 | 63,085 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 14 Dec 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 30 Nov 2021 | 15,125 | 122,825 (0%) | 0% | 1.5 | 23,141 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 15,125 | 230,505 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 30 Nov 2021 | 13,750 | 107,700 (0%) | 0% | 50 | 687,500 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 45.60 per share. | 30 Nov 2021 | 1,375 | 121,450 (0%) | 0% | 45.6 | 62,700 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 32.67 per share. | 16 Nov 2021 | 1,375 | 107,700 (0%) | 0% | 32.7 | 44,921 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 1,375 | 245,630 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 16 Nov 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 36.94 per share. | 02 Nov 2021 | 1,375 | 107,700 (0%) | 0% | 36.9 | 50,793 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 1,375 | 247,005 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 02 Nov 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 38.87 per share. | 19 Oct 2021 | 1,375 | 107,700 (0%) | 0% | 38.9 | 53,446 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 19 Oct 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2021 | 1,375 | 248,380 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 33.75 per share. | 05 Oct 2021 | 1,375 | 107,700 (0%) | 0% | 33.7 | 46,406 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 1,375 | 249,755 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 05 Oct 2021 | 1,375 | 109,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Sep 2021 | 8,000 | 251,130 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 22 Sep 2021 | 8,000 | 107,700 (0%) | 0% | 1.5 | 12,240 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 21 Sep 2021 | 4,125 | 99,700 (0%) | 0% | 50 | 206,250 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Sep 2021 | 4,125 | 259,130 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 21 Sep 2021 | 4,125 | 103,825 (0%) | 0% | 1.5 | 6,311 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 07 Sep 2021 | 4,125 | 103,825 (0%) | 0% | 1.5 | 6,311 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 4,125 | 263,255 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 07 Sep 2021 | 2,750 | 99,700 (0%) | 0% | 50 | 137,500 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 49.00 per share. | 07 Sep 2021 | 1,375 | 102,450 (0%) | 0% | 49 | 67,375 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 25 Aug 2021 | 2,750 | 99,700 (0%) | 0% | 50 | 137,500 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 25 Aug 2021 | 2,750 | 102,450 (0%) | 0% | 1.5 | 4,208 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2021 | 2,750 | 267,380 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 24 Aug 2021 | 1,375 | 99,700 (0%) | 0% | 48 | 66,000 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2021 | 1,375 | 270,130 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 24 Aug 2021 | 1,375 | 101,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 23 Aug 2021 | 13,750 | 99,700 (0%) | 0% | 50 | 687,500 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 13,750 | 271,505 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 23 Aug 2021 | 13,750 | 113,450 (0%) | 0% | 1.5 | 21,038 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 41.00 per share. | 10 Aug 2021 | 1,375 | 99,700 (0%) | 0% | 41 | 56,375 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 1,375 | 285,255 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 10 Aug 2021 | 1,375 | 101,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 36.72 per share. | 27 Jul 2021 | 1,375 | 99,700 (0%) | 0% | 36.7 | 50,490 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2021 | 1,375 | 286,630 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 27 Jul 2021 | 1,375 | 101,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2021 | 1,375 | 288,005 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 13 Jul 2021 | 1,375 | 101,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 36.72 per share. | 13 Jul 2021 | 1,375 | 99,700 (0%) | 0% | 36.7 | 50,490 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 1,375 | 289,380 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 46.63 per share. | 29 Jun 2021 | 1,375 | 99,700 (0%) | 0% | 46.6 | 64,116 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 29 Jun 2021 | 1,375 | 101,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2021 | 8,000 | 290,755 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 23 Jun 2021 | 8,000 | 99,700 (0%) | 0% | 1.5 | 12,240 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 15 Jun 2021 | 1,375 | 93,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 1,375 | 298,755 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 45.29 per share. | 15 Jun 2021 | 1,375 | 91,700 (0%) | 0% | 45.3 | 62,274 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,375 | 300,130 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 01 Jun 2021 | 1,375 | 93,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 42.51 per share. | 01 Jun 2021 | 1,375 | 91,700 (0%) | 0% | 42.5 | 58,451 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 45.03 per share. | 18 May 2021 | 1,375 | 91,700 (0%) | 0% | 45.0 | 61,916 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 1,375 | 301,505 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 18 May 2021 | 1,375 | 93,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 46.03 per share. | 04 May 2021 | 1,375 | 91,700 (0%) | 0% | 46.0 | 63,291 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2021 | 1,375 | 302,880 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 04 May 2021 | 1,375 | 93,075 (0%) | 0% | 1.5 | 2,104 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 49.50 per share. | 27 Apr 2021 | 7,900 | 91,700 (0%) | 0% | 49.5 | 391,077 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2021 | 7,900 | 304,255 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 27 Apr 2021 | 7,900 | 99,600 (0%) | 0% | 1.5 | 12,087 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 19 Apr 2021 | 2,340 | 91,700 (0%) | 0% | 48 | 112,320 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2021 | 2,340 | 312,155 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 19 Apr 2021 | 2,340 | 94,040 (0%) | 0% | 1.5 | 3,580 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 3,500 | 314,495 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 16 Apr 2021 | 3,500 | 91,700 (0%) | 0% | 1.5 | 5,355 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.53 per share. | 13 Apr 2021 | 5,560 | 93,760 (0%) | 0% | 1.5 | 8,507 | Common Stock |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 5,560 | 317,995 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Herbert Virgin | EVP, Research & CSO | Sale of securities on an exchange or to another person at price $ 43.57 per share. | 13 Apr 2021 | 5,560 | 88,200 (0%) | 0% | 43.6 | 242,244 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges